PATENT CLAIM ANALYSIS

Application Number: 16020457
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["514", "635000"]

Abstract:
Provided herein are methods for treating subjects having conditions related to adrenocortical activity and/or excessive steroid production. In particular, provided herein are methods for treating subjects having conditions related to adrenocortical activity and/or excessive steroid production through administration of at least one of the following agents: 1) an agent capable of inhibiting cholesterol efflux related to ABCA1 and/or ABCG1; 2) an agent capable of inhibiting MDR1 related cortisol secretion and/or MDR1 P-glycoprotein multiple drug transporter activity; and 3) an agent capable of inhibiting mitochondrial activity.

Claim (Index 10):
The kit of  claim 9 , further comprising one or more anticancer agents, wherein the agent capable of inhibiting cholesterol efflux related to ABCA1 and/or ABCG1 is selected from Valspodar, Glyburide, Cyclosporine A.

Metadata:
- Claim Count in Document: 33.0
- Percentile: 94.0
- Lexical Diversity: 1.74074
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13802047', '15170682', '14798237', '14894281', '14148241']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7655800069404244
- 35 USC 102 Novelty (BERT): 0.5240781791336561
- Combined Prediction Score: 0.7414298241597476
- Mean Citation Score: 276.233942
- Max Citation Score: 313.12173
- Similarity Product: 182.55898440885545

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test